FDA panel recommends Roche's valganciclovir

The FDA's Anti-Viral Drugs Advisory Committee voted 12-1 to recommend marketing approval of Roche's valganciclovir, a prodrug of the company's Cytovene ganciclovir, to treat cytomegalovirus (CMV) reti...